<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04974762</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-18-00379</org_study_id>
    <nct_id>NCT04974762</nct_id>
  </id_info>
  <brief_title>Truncal Blocks Versus Wound Infiltration for SICD</brief_title>
  <official_title>Comparing Truncal Blocks Versus Wound Infiltration for Subcutaneous Implantable Cardioverter Defibrillator Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center, randomized and prospective trial of all patients undergoing S-ICD&#xD;
      implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and&#xD;
      eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be&#xD;
      randomized to receive either surgical infiltration of local anesthetic or truncal blocks.&#xD;
      Intraoperative and postoperative data will be collected including total opioid use, pain&#xD;
      scores postprocedure, total postoperative narcotic need and length of stay.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, randomized and prospective trial of all patients undergoing S-ICD&#xD;
      implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and&#xD;
      eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be&#xD;
      randomized to receive either surgical infiltration of local anesthetic or truncal blocks.&#xD;
      Intraoperative and postoperative data will be collected including total opioid use, pain&#xD;
      scores postprocedure, total postoperative narcotic need and length of stay. The procedures&#xD;
      involved for the study are the placement of the described truncal blocks or wound&#xD;
      infiltration. Data to be collected are patient demographics, history of present illness, past&#xD;
      medical history, and pain management techniques required (i.e non-narcotics and narcotics&#xD;
      use). In addition, age, race, gender and BMI will also be collected. Intraoperative analgesia&#xD;
      requirements, postoperative analgesia requirements, duration of procedure and length of stay&#xD;
      will also be collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2019</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>The researcher assessing the subjects postoperatively will be different from the anesthesiologist that performs the interventions.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative and postoperative opioid consumption</measure>
    <time_frame>Up to Post-Op Day 10</time_frame>
    <description>Total intraoperative and postoperative opioid consumption of subjects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non-opioid analgesic consumption</measure>
    <time_frame>Up to Post-Op Day 10</time_frame>
    <description>Total intraoperative and postoperative non-opioid analgesic consumption of subjects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation (propofol) requirements intraoperatively</measure>
    <time_frame>Day 1, Day of Surgery</time_frame>
    <description>Total propofol required by subjects intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with ICU stay</measure>
    <time_frame>Up to Post-Op Day 10</time_frame>
    <description>Need of intensive care unit (ICU) stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>Up to Post-Op Day 10</time_frame>
    <description>Duration of intensive care unit (ICU) stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain score</measure>
    <time_frame>Up to Post-Op Day 10</time_frame>
    <description>Visual Analog Pain Score (VAS) - total scale from 0-10, with higher score indicating more pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>Day 1 at Surgery</time_frame>
    <description>Total duration of procedure time measured in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Day 1 at Surgery</time_frame>
    <description>Length of time in the postanesthesia care unit measured in minutes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Intraoperative Pain</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Wound infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard intervention - surgical infiltration with local anesthetics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Truncal blocks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Truncal block for anesthetics</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Wound infiltration</intervention_name>
    <description>Surgical wound infiltration by proceduralist</description>
    <arm_group_label>Wound infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Truncal blocks</intervention_name>
    <description>Truncal blocks provided by anesthesiology team for device placement</description>
    <arm_group_label>Truncal blocks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years of age&#xD;
&#xD;
          -  Patients undergoing S-ICD placement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to amide local anesthetics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Shariat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Shariat, MD</last_name>
    <phone>212-523-6121</phone>
    <email>alishariatmd@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mount Sinai Morningside Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ali Shariat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2021</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Ali Nima Shariat</investigator_full_name>
    <investigator_title>Assistant Professor, Anesthesiology, Perioperative &amp; Pain Medicine</investigator_title>
  </responsible_party>
  <keyword>Subcutaneous implantable cardioverter-defibrillators (S-ICD)</keyword>
  <keyword>Truncal blocks</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

